RENISHAW NEURO SOLUTIONS LTD
Get an alert when RENISHAW NEURO SOLUTIONS LTD files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Cash
£521K
+302.3% highest in 3 filed years
Net assets
-£21M
-29.5% lowest in 3 filed years
Employees
47
+6.8% vs 2024
Profit before tax
-£6.5M
+16.5% highest in 3 filed years
Watchouts
Facts from the Companies House register and the latest accounts — not a rating
-
Negative shareholders' funds
Net assets
3-year trend · vs Technology median
Accounts
3-year trend · Δ = latest vs prior filed period · latest reflected 2025-06-30
| Metric | Trend | 2023-06-30 | 2024-06-30 | 2025-06-30 | Δ vs prior |
|---|---|---|---|---|---|
| Turnover | £2,167,881 | £2,549,758 | £3,039,437 | +19.2% | |
| Operating profit | -£6,165,530 | -£6,757,441 | -£5,288,503 | +21.7% | |
| Profit before tax | -£6,814,938 | -£7,796,731 | -£6,511,619 | +16.5% | |
| Net profit | -£5,371,478 | -£5,852,923 | -£4,895,980 | +16.3% | |
| Cash | £180,300 | £129,595 | £521,405 | +302.3% | |
| Total assets less current liabilities | £7,219,230 | £5,287,179 | £5,315,410 | +0.5% | |
| Net assets | -£10,726,807 | -£16,579,730 | -£21,475,710 | -29.5% | |
| Equity | -£10,726,807 | — | — | — | |
| Average employees | 47 | 44 | 47 | +6.8% | |
| Wages | £2,454,149 | £2,773,503 | £2,865,075 | +3.3% | |
| Directors' remuneration | £256,215 | £267,120 | £278,387 | +4.2% |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. The Δ column is the change from the prior filed period as a percentage of |prior|; lines a company doesn't report show —. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-06-30 | 2024-06-30 | 2025-06-30 |
|---|---|---|---|---|
| Operating margin | — | — | -174.0% | |
| Net margin | — | — | -161.1% | |
| Return on capital employed | -85.4% | -127.8% | -99.5% | |
| Gearing (liabilities / total assets) | — | 371.4% | 420.6% | |
| Current ratio | 3.12x | 3.85x | 2.72x | |
| Interest cover | -9.19x | -6.14x | -4.11x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Margin ratios are hidden where reported turnover is too small relative to profit to yield a meaningful figure — typical of holding companies whose income is mostly subsidiary dividends rather than trading revenue. Sector-distribution context coming next.
Name history
Renamed 1 time since incorporation
- RENISHAW NEURO SOLUTIONS LTD 2016-12-13 → present
- HOP TO BUSINESS LIMITED 2016-09-14 → 2016-12-13
Audit & accounting basis
- Accounting basis
- FRS 101
- Reporting scope
- Standalone (parent only)
- Auditor
- Ernst & Young LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“In preparing these financial statements, the Directors have adopted the going concern basis. The Company's parent undertaking, Renishaw plc, has provided a letter of support in meeting financial obligations for a period to 30 April 2027. The Directors have considered the company resources as well as the ability of Renishaw plc to provide support and have concluded that it is reasonable to continue adopting the going concern basis of accounting.”
Group structure
- RENISHAW NEURO SOLUTIONS LTD · parent
- Renishaw Mayfield Sarl 100%
Significant events
- “On 1 April 2025 it was announced that the ultimate parent, Renishaw plc, would move forward with its proposal to close the drug delivery aspect of the Company.”
- “On 7 October 2025, the critical supplier for the surgical robots used in neurological procedures announced its decision to cease manufacturing of the products.”
- “On 31 October 2025, the drug delivery business was sold for total proceeds of £250,000, with all assets written down to their recoverable amount at 30 June 2025.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
3 active · 7 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| CALLANAN, Louise | Director | 2025-11-26 | Jan 1975 | Irish |
| SAUNDERS, Marc Thomas Berkeley | Director | 2025-05-01 | Aug 1968 | British |
| TURL, Lee | Director | 2025-05-01 | Sep 1978 | British |
Show 7 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| RICHARDS-GARCIA, Vilma Constanza | Secretary | 2017-08-26 | 2023-11-15 |
| TANG, Norma Shau Yee | Secretary | 2016-12-12 | 2017-08-26 |
| DEER, Daniel John | Director | 2017-08-23 | 2020-02-03 |
| JONES, Rupert Peregrin | Director | 2017-08-23 | 2025-05-01 |
| ROBERTS, Allen Christopher George | Director | 2016-12-12 | 2025-11-26 |
| SKINNER, Paul Jonathan | Director | 2017-08-23 | 2026-03-26 |
| THORNTON, Bryan Anthony | Director | 2016-09-14 | 2016-12-12 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Renishaw Plc | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2019-12-16 | Active |
| Renishaw Medical Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2017-08-23 | Ceased 2019-12-16 |
| Renishaw Plc | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2016-12-12 | Ceased 2017-08-23 |
| Cfs Secretaries Limited | Corporate entity | Shares 75–100%, Appoints directors, Significant influence | 2016-09-14 | Ceased 2016-12-12 |
| Mr Bryan Anthony Thornton | Individual | Appoints directors, Significant influence | 2016-09-14 | Ceased 2016-12-12 |
Filing timeline
Last 20 of 49 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-06-30 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2026-06-19 | AA | accounts | Accounts with accounts type full | |
| 2026-04-08 | TM01 | officers | Termination director company with name termination date | |
| 2025-12-08 | AP01 | officers | Appoint person director company with name date | |
| 2025-12-01 | TM01 | officers | Termination director company with name termination date | |
| 2025-07-03 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-06-10 | AA | accounts | Accounts with accounts type full | |
| 2025-06-10 | AP01 | officers | Appoint person director company with name date | |
| 2025-05-23 | AP01 | officers | Appoint person director company with name date | |
| 2025-05-23 | TM01 | officers | Termination director company with name termination date | |
| 2024-07-03 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-04-08 | AA | accounts | Accounts with accounts type full | |
| 2023-11-15 | TM02 | officers | Termination secretary company with name termination date | |
| 2023-07-14 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-03-14 | AA | accounts | Accounts with accounts type full | |
| 2022-07-08 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2022-05-31 | AA | accounts | Accounts with accounts type full | |
| 2021-07-08 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2021-07-04 | AA | accounts | Accounts with accounts type full | |
| 2020-07-20 | CS01 | confirmation-statement | Confirmation statement with updates |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 6
- Capital events
- 0
- Officers appointed
- 1
- Officers resigned
- 2
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.